UCLA Hematology-Oncology Santa Monica
Santa Monica, California 90404
We've found
7 trials
at this facility
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Clinical Trial
Updated: 12/31/1969
A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study of Talazoparib
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
GIST Clinical Trial
Updated: 12/31/1969
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials